| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b67d9458b46d03d5c803e809bd5ed052 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-424 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 |
| filingDate |
2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68a017d63ef996ce82e54cfab07a613e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5dcbf69e055c8c179240bd6266f8a7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd96492df7db82b6a11a92a38d3cf69c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_655b26511d2f1bad1829ae7b6ec07fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1a2c853260205c6f6e71c4cb4e7403c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23e8bba445d29d2f1c670c1a0031da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ae39e18ad445dc880f4cfa2a6bb4cdf |
| publicationDate |
2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202114713-A |
| titleOfInvention |
Disulfide-crosslinked hyaluronic acid hydrogels for preventing tissue adhesions caused by abdominal (pelvic) surgeries and preparation method thereof |
| abstract |
The present invention discloses disulfide-crosslinked hyaluronic acid hydrogels for preventing tissue adhesions caused by abdominal (pelvic) surgeries, and the amount of the disulfide-crosslinked hyaluronic acid ranges from 3 to 8 mg/ml. The disulfide-crosslinked hyaluronic acid hydrogel in the present invention has remarkable advantages of good biocompatibility and a good preventive effect on tissue adhesion, while used for the prevention of tissue adhesions caused by abdominal (pelvic) surgeries. The present invention also provides a preparation method of disulfide-crosslinked hyaluronic acid hydrogels for preventing tissue adhesions caused by abdominal (pelvic) surgeries. |
| priorityDate |
2019-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |